Outcomes With First‐Line PD1 Inhibitors in Extranodal NK/T‐Cell Lymphoma: A Comparative Analysis From a 755‐Patient Multicenter Cohort
Year: 2026
Type: article
Study design: Observational Study
Source: American Journal of Hematology
DOI: 10.1002/ajh.70341
Institutions: Jiangsu Province Hospital, Nanjing Medical University, Northern Jiangsu People's Hospital, Yangzhou University, Huaian First People’s Hospital, The Affiliated Yongchuan Hospital of Chongqing Medical University, Ningbo University, Ningbo First Hospital, First Affiliated Hospital of Zhengzhou University, Changzhou No.2 People's Hospital, Nantong University, Affiliated Hospital of Nantong University, Nanjing Jiangning Hospital, Harbin Medical University, Second Affiliated Hospital of Harbin Medical University, Affiliated Hospital of Qingdao University, University of Science and Technology of China
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: G4998876820, G6696413967, G7045651186
OpenAlex ID: W7155703043
